In bladder cancer, TFAP2C transcriptionally increases prostate cancer associated transcript 1 (PCAT1) expression, which physically interacts with c-Myc to transcriptionally activate SLC7A11 expression. The gene discussed is PCAT1; the disease is urinary bladder carcinoma.